Biotech Growth Investors & VC Firms
708 firms in this list, with a median first check of $1M. 169 of them lead rounds. Generated from verified public data and updated continuously.
Premium Equity Partners
Frankfurt am MainGrowth
6 people
The Wells Investment
SeoulSeed–Late Stage
GERBER-RAUTH
MilanPre-Seed–Late Stage
Seoul Investment Partners
SeoulSeed–Late Stage
CIBC
TorontoPre-Seed–Late Stage$1.5M – $29.2M
1 person
IMM Investment
KangnamPre-Seed–Growth
Onex Corporation
TorontoGrowth–Late Stage
GBS Venture Partners Ltd.
MelbourneSeed–Growth$165K – $7.9M
2 people
CDF-Capital
ShenzhenSeed–Late Stage
Creafund Asset Management nv
Sint-Martens-LatemGrowth$5.4M – $27M
3 people
Hiroshima Innovation Network
HiroshimaPre-Seed–Growth
Impulsora de Innovacion Mexico
Mexico CitySeed–Growth$1M
Laval Innov
LavalPre-Seed–Late Stage
National Bank Technology Banking
MontrealGrowth
Teewinot Ventures
Pre-Seed–Late Stage
Zhangjiang Hi-Tech incubation ecosystem
ShanghaiPre-Seed–Growth
Capital Medica Ventures
TokyoPre-Seed–Growth
3 people
Morningside Group
Hong KongSeed–Growth
1 person
ePlanet Capital
San JoseSeed–Late Stage
3 people
Hong Kong Science and Technology Parks – incubation programs
Hong KongPre-Seed–Growth
4 people
Japan Asia Investment
TokyoPre-Seed–Late Stage$1M – $10M
1 person
Omron Ventures
KyotoSeed–Growth
2 people
Advantech Capital
Camana BayGrowth
3 people
Wild Basin Investments
TexasSeed–Growth
2 people
Related lists
Growth Investors & VC Firms (4263)Biotech Investors & VC Firms (2475)Growth Investors & VC Firms in North America (2121)Biotech Seed Investors & VC Firms (2020)Growth Investors & VC Firms in United States (1837)Growth Investors & VC Firms in Europe (1633)Biotech Series A Investors & VC Firms (1626)Biotech Investors & VC Firms in North America (1594)Biotech Investors & VC Firms in United States (1445)Growth Investors & VC Firms in Global (1377)
Data sourced from public filings and firms' own websites — see our methodology.








